RSS Items

Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid jabs

Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid-19 jabs

UK pharma group agrees to buy Seattle-based biotech Icosavax

Deal with Absci is the latest between big pharma and tech companies to build new disease treatments

Anglo-Swedish drugmaker targets $80bn in revenue by 2030

Best-selling Tagrisso drug slows progression of most common form of the disease at an early stage

James Muir was discriminated against on the basis of his mental health disability

GQG Partners argues that pharma group has performed strongly under long-serving chief

Pharmaceutical group confirms four other current and ex-executives investigated, in addition to Leon Wang

On staying fit enough for space and approaching risky endeavours with caution